Terms: = Ovarian cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Treatment
7 results:
1. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract] [Full Text] [Related]
2. Histopathology Discrepancy of Preoperative Endometrial Sampling and Final Specimen: How Does This Influence Selective Lymph Node Dissection?
Corr BR; Carrubba A; Sheeder J; Cheng G; Guntupalli SR
Int J Gynecol Cancer; 2017 Feb; 27(2):297-301. PubMed ID: 27870710
[TBL] [Abstract] [Full Text] [Related]
3. The impact of qualitative research on gynaecologic oncology guidelines.
How JA; Abitbol J; Lau S; Gotlieb WH; Abenhaim HA
J Obstet Gynaecol Can; 2015 Feb; 37(2):138-144. PubMed ID: 25767946
[TBL] [Abstract] [Full Text] [Related]
4. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
[TBL] [Abstract] [Full Text] [Related]
5. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K
Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451
[TBL] [Abstract] [Full Text] [Related]
6. [Promoter hypermethylation gene patterns in gynecological tumors].
Leal Rojas P; Anabalón Rodríguez L; García Muñoz P; Tapia Escalona O; Guzmán González P; Araya Orostica JC; Villaseca Hernández M; Roa Strauch JC
Med Clin (Barc); 2009 Mar; 132(10):371-6. PubMed ID: 19268989
[TBL] [Abstract] [Full Text] [Related]
7. CpG methylation of the fhit, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract] [Full Text] [Related]
